Who are the top-tier private equity firms that are starting to do earlier, growth-stage deals?

The traditional line between mega-buyout private equity (PE) and early-stage venture capital (VC) has blurred significantly . Large-cap and traditional PE shops—pushed by massive pools of dry powder and fierce competition in late-stage dealmaking—have steadily moved down-market into growth equity and earlier-stage minority or growth-buyout investments.

Top-tier traditional and mega-PE firms (alongside hybrid giants) that have built out dedicated strategies or funds to capture earlier growth-stage and emerging technology/healthcare deals include:

• Blackstone Growth (BXG) : Launched as Blackstone’s dedicated growth equity arm, BXG focuses on investing in high-growth, entrepreneurial companies in sectors like software, enterprise, and consumer. While it doesn't do seed rounds, it frequently participates in earlier growth/expansion phases (such as Series B and C) that were once exclusively the domain of traditional VCs.
• KKR (Next Generation Technology / Growth Strategy) : KKR expanded aggressively down-market with dedicated tech growth vehicles (like its Next Generation Technology Fund series). They routinely target emerging, high-growth tech and software enterprises earlier in their lifecycle than KKR's traditional control-buyout funds would ever venture.
• Bain Capital (Bain Capital Ventures & Co-investments) : While Bain Capital Ventures (BCV) has long operated as the venture arm, the broader Bain ecosystem has increasingly coordinated cross-stage investments, allowing them to bridge early venture all the way to scaled growth.
• Insight Partners : Blurring the lines between venture capital and private equity perhaps better than any firm of its scale, Insight operates an expansive "ScaleUp" software playbook. They routinely lead early growth rounds (Series B/C) while retaining the capability to transition those same companies into majority private equity buyouts later.
• TPG Growth : TPG was an early mover among mega-PE firms, launching its dedicated growth platform back in 2007. They specifically target earlier-stage, high-growth companies offering minority growth stakes, growth buyouts, and structured capital.
• General Atlantic : Known historically as a growth equity pioneer, General Atlantic sits squarely in the middle, targeting high-growth businesses with strong secular tailwinds well before they reach mature buyout status.
• Battery Ventures : Operating a multi-stage model, Battery bridges everything from seed and early-stage tech development up to private equity buyouts, giving them a continuous view of a company's lifecycle.

Would you like to explore how the deal terms (like liquidation preferences or governance rights) differ when a mega-PE firm leads an early growth round versus a traditional VC?

Yes. There’s a meaningful shift happening: large, brand-name PE firms are moving “left” into growth equity and earlier-stage private-company investing, partly because traditional buyout valuations are competitive and partly because the best companies are staying private longer. Growth equity was already 21% of U.S. PE deal count in 2025, and growth funds attracted a record $33.2B in the first half of 2026.

If by “top-tier PE” you mean firms with serious institutional scale/brand, but that will consider companies earlier than the classic $500M+ EBITDA buyout, I'd put these near the top:

The firms I'd prioritize

1. TPG / TPG Growth — probably the clearest answer

TPG explicitly says its Growth platform exists to invest in companies that are “earlier in their lifecycle” and smaller than the companies targeted by its main Capital platform. TPG launched Growth in 2007 and does everything from minority growth investments through growth buyouts. Its Growth platform now has roughly $35B of AUM.

This is exactly the model you're describing: mega-fund PE infrastructure + growth-stage entry point.

2. Insight Partners — arguably the most aggressive at moving early

Insight is somewhat different because it's really a growth/PE platform rather than a traditional buyout firm that recently discovered growth. But it's one of the best examples of a giant institutional investor moving earlier.

Insight says it invests from seed through late stage, and its current strategy is explicitly stage-agnostic. www.insightpartners.com It says it still writes $5M–$20M growth checks and has investors specifically focused on early-growth opportunities.

For software/AI, I'd put Insight in the absolute top tier.

3. General Atlantic

GA is another firm where “growth equity” has effectively become a major institutional asset class in its own right. It's particularly relevant if you're looking for companies that have real revenue and product-market fit but are still too early for traditional buyout PE.

The distinction is important: GA isn't necessarily “a buyout firm moving down-market”; it's more accurate to call it a premier growth-equity firm operating at PE scale.

4. Summit Partners

Summit is extremely relevant if you're looking for profitable, high-growth companies rather than venture-stage businesses. It has been doing this since 1984 and explicitly describes itself as bridging early-stage VC and traditional PE.

Its latest flagship growth fund raised $9.5B, with investments generally ranging from $75M–$500M for that fund. growthcapadvisory.com Its broader stated investment range is $10M–$500M+.

5. Bain Capital

Bain is especially interesting because it has built a genuinely broad technology investing ecosystem. The firm says it backs technology companies “from Seed to Scale,” including pre-revenue seed investments and growth equity.

Its venture arm currently says investments can range from $1M seed checks to $100M growth-equity investments.

So if you're asking, “Which elite PE firms could potentially meet a company substantially earlier than their flagship buyout fund?” Bain belongs near the top.

6. EQT

EQT has built an unusually comprehensive technology ecosystem: EQT Ventures → EQT Growth → EQT Private Equity. Its Growth strategy specifically targets European/Israeli growth-stage technology companies, while Ventures goes into early-stage tech.

That's an attractive setup for founders because the firm can theoretically support a company through multiple stages of maturity.

---

The interesting second tier

Blackstone is worth watching, but I'd characterize it as “expanding its opportunity set” rather than becoming an early-stage investor. Its core PE strategy remains much larger and later-stage. It is nevertheless increasingly willing to do founder-partnered growth investments; for example, its 2026 FUTRONIC investment involved the founder remaining CEO while Blackstone provided capital to accelerate expansion.

KKR similarly has enormous flexibility across strategies. Its K-PRIME portfolio, for example, explicitly includes growth equity alongside buyout, core, mid-market and other strategies. kseries.kkr.com But I'd still view KKR as more “flexible mega-platform” than a dedicated early-growth investor.

Thoma Bravo is fascinating if you're in software. Its Discover strategy is specifically aimed at smaller/midsize software companies, alongside its giant flagship funds. It raised an $8.1B Discover V fund in 2025.

---

My ranking if you're actually trying to raise money

If the company is, say, $20–100M revenue, growing 30–100%+, strong product-market fit, and not yet a conventional PE buyout candidate, I'd prioritize:

Tier 1

1. Insight Partners
2. General Atlantic
3. TPG Growth
4. Summit Partners
5. Bain Capital

Tier 1.5 / highly situation-dependent 6. EQT Growth 7. Thoma Bravo Discover — especially software 8. Blackstone Growth / PE 9. KKR 10. Carlyle

The key distinction I'd make is “PE firms moving earlier” vs. “growth firms that have always invested earlier.” Insight, GA and Summit are fundamentally growth investors. TPG, Bain, EQT, Blackstone and KKR are more interesting examples of huge multi-strategy PE organizations building channels into earlier-stage companies.

And that distinction matters a lot when you're assessing who is actually likely to compete for a $30–100M growth round, rather than merely having a growth strategy on its website.

The boundary between traditional mega-buyout private equity (PE) and early-to-growth-stage investing has blurred significantly. Facing a hyper-competitive landscape for late-stage deals and a shifting macroeconomic climate, top-tier PE powerhouses and dedicated growth platforms have moved "upstream" or "downstream" into earlier growth-stage and Series A/B/C territory.

The prominent tier-one private equity and hybrid growth-equity firms aggressively planting flags earlier in the company lifecycle include:

• Insight Partners — Long known as a hybrid giant straddling venture capital and growth PE , Insight frequently leads early Series A and B rounds despite managing a massive pool of capital . They approach early growth with an operational scale usually reserved for mature PE.
• KKR (KKR Growth) — KKR’s dedicated growth equity arm actively targets high-expansion companies before they reach traditional buyout maturity, writing checks that bridge aggressive late-stage tech scaling and early commercial maturity.
• Bain Capital (Bain Capital Ventures) — While Bain Capital dominates traditional control buyouts, its venture and growth affiliate, Bain Capital Ventures, operates seamlessly from seed and early-stage infrastructure up to growth rounds , giving portfolio companies a direct pipeline into heavy-duty PE operational muscle later on.
• Thoma Bravo — Primarily a software-focused buyout titan, Thoma Bravo has increasingly looked at earlier growth-equity opportunities and minority co-investments to secure relationships with emerging enterprise software category leaders before competitors crowd them out.
• General Atlantic — A pioneer of growth equity , General Atlantic continues to pull earlier into the tech and healthcare lifecycle, utilizing dedicated global sector teams to back high-growth disruptors at earlier inflection points than standard buyout shops.
• Summit Partners — Known historically for growth equity and expanding the middle ground between venture capital and traditional PE , Summit routinely targets earlier, high-velocity product-expansion phases in tech and healthcare.

If you're focusing on a specific sector like enterprise software, healthcare/biotech , or fintech , I can narrow down which of these firms are most active at the Series A vs. Series B/C level.

Yes. If by “earlier” you mean firms with top-tier PE brands that are moving down from traditional LBO territory into Series B/C/D-ish, $20–100M+ growth rounds, there’s a meaningful group to watch.

The important distinction is between true growth investors and traditional mega-funds that occasionally do a growth deal.

The strongest names

If you're specifically looking for firms moving down-market

I'd put these at the top of the list:

1. General Atlantic Probably the cleanest “elite PE-quality investor that will still meet you before you're enormous” answer. GA has been doing growth equity since 1980 and explicitly targets both established and emerging business models, including SMB software and AI/ML.

2. TPG Growth This is particularly interesting because TPG itself says its Growth platform exists to invest in companies that are “earlier in their lifecycle” and smaller than the companies targeted by its traditional Capital strategy.

3. Summit Partners One of the classic growth-equity franchises. Summit describes its strategy as bridging the gap between early-stage VC and traditional PE, and it does both minority growth and growth buyouts.

4. Insight Partners Especially compelling for SaaS/AI/enterprise software. Insight has historically been unusually willing to span the spectrum from growth investments through larger buyouts.

5. Warburg Pincus A very strong option if you're already substantial but don't want to wait until you're a conventional PE-sized company.

6. TA Associates Similar story: extremely established growth investor, but with the ability to move into control transactions as companies mature.

The interesting trend in 2026

This isn't just your imagination. Growth equity is attracting substantially more institutional capital right now. U.S. growth funds raised $33.2B in H1 2026, up 36% from H1 2025, with capital concentrating in a handful of large managers.

And the strategic rationale is pretty straightforward: traditional PE firms have enormous pools of capital, while many of the most attractive companies now stay private longer. So the big firms increasingly want to establish relationships before a company is large enough for a $500M+ LBO.

My “who should I actually call?” ranking

If you're a high-growth company that is too mature for normal VC but too early for a traditional mega-fund buyout, I'd prioritize:

1. General Atlantic
2. TPG Growth
3. Insight Partners
4. Summit Partners
5. TA Associates
6. Warburg Pincus
7. Bain Capital Growth
8. KKR Growth
9. Blackstone Growth
10. Permira Growth

One nuance: “top-tier” and “earliest” are inversely correlated. The more genuinely early you are (say, $10–30M revenue), the more I'd favor the dedicated growth franchises like GA, Summit, TPG Growth, Insight, etc. If you're at $50–200M+ revenue with strong EBITDA or a clear path to it, the mega-funds become much more relevant.

If you tell me roughly revenue / growth rate / EBITDA / valuation / sector, I can narrow this to the 10–15 firms most likely to actually compete for your deal, including typical check size and whether they'd want minority vs. control.

I'd put these at the top of the list:

1. General Atlantic Probably the cleanest “elite PE-quality investor that will still meet you before you're enormous” answer. GA has been doing growth equity since 1980 and explicitly targets both established and emerging business models, including SMB software and AI/ML.

2. TPG Growth This is particularly interesting because TPG itself says its Growth platform exists to invest in companies that are “earlier in their lifecycle” and smaller than the companies targeted by its traditional Capital strategy.

3. Summit Partners One of the classic growth-equity franchises. Summit describes its strategy as bridging the gap between early-stage VC and traditional PE, and it does both minority growth and growth buyouts.

4. Insight Partners Especially compelling for SaaS/AI/enterprise software. Insight has historically been unusually willing to span the spectrum from growth investments through larger buyouts.

5. Warburg Pincus A very strong option if you're already substantial but don't want to wait until you're a conventional PE-sized company.

6. TA Associates Similar story: extremely established growth investor, but with the ability to move into control transactions as companies mature.

The interesting trend in 2026

This isn't just your imagination. Growth equity is attracting substantially more institutional capital right now. U.S. growth funds raised $33.2B in H1 2026, up 36% from H1 2025, with capital concentrating in a handful of large managers.

And the strategic rationale is pretty straightforward: traditional PE firms have enormous pools of capital, while many of the most attractive companies now stay private longer. So the big firms increasingly want to establish relationships before a company is large enough for a $500M+ LBO.

My “who should I actually call?” ranking

Yes. There’s a real migration of blue-chip buyout firms downmarket into growth equity / late-stage venture, especially where companies have meaningful revenue, strong growth, and a path to $100M+ EBITDA or an eventual IPO. Growth equity itself is having a strong 2026, with late-stage private-company investment running at its strongest pace since 2021.

If by “top-tier” you mean firms with the brand, capital base, and ability to write very large checks—but increasingly willing to invest before a traditional LBO—I'd put these at the top:

The ones I'd focus on most

1. TPG Growth

This is probably the archetype you're asking about. TPG explicitly says its Growth platform invests in companies “earlier in their lifecycle” and “smaller in size” than its traditional Capital strategy, ranging from minority growth investments to growth buyouts. It currently reports about $32B of AUM in the platform.

2. General Atlantic

GA is arguably the gold-standard name if you're talking about growth equity rather than traditional PE. It's historically built around investing in high-growth companies before they become obvious mega-cap buyout targets. It now manages roughly $130B overall, with investments including companies such as Anthropic and Vuori.

3. EQT Growth

EQT is particularly interesting because it's a huge global PE franchise but has deliberately built a true growth-equity capability rather than simply moving its buyout team slightly earlier. I'd put it near the top of the list for a company raising a substantial Series B/C/D-type round.

4. Insight Partners

Insight has long been one of the most important crossover firms between VC and PE. It's particularly formidable for software, data, cybersecurity and enterprise technology. The firm was already #7 in Buyouts' 2025 ranking of PE firms by five-year fundraising, illustrating how substantial the platform has become.

5. KKR

KKR is an interesting one if you're specifically looking for a PE firm that's moving earlier. Its enormous balance sheet lets it do things that traditional growth funds can't. The distinction is that KKR is still fundamentally a diversified private-markets giant rather than a pure growth-equity house. It ranked #1 in PEI's 2026 PE fundraising ranking.

A useful way to segment them

If you're trying to identify investors for a company, I'd think about them this way:

Series B/C-ish — genuine growth capital

• TPG Growth
• EQT Growth
• General Atlantic
• Insight Partners
• Bain Capital Growth
• Bessemer / Coatue / ICONIQ (not traditional PE, but often competitive here)

Series C/D through pre-IPO — crossover PE/growth

• General Atlantic
• Insight
• TPG
• KKR
• Silver Lake
• Blackstone
• Goldman Sachs Asset Management
• Carlyle

$100M+ revenue / approaching profitability — “PE that will invest early”

• TPG
• KKR
• Bain
• Blackstone
• Advent
• EQT
• Thoma Bravo
• Silver Lake

The important distinction is that “earlier” doesn't necessarily mean early-stage VC. These firms generally want de-risked growth: proven product-market fit, substantial revenue, strong growth, and enough scale that they can underwrite the business on financial metrics rather than venture-style optionality. That's consistent with how growth equity is currently defined across the market.

And the trend is meaningful: companies are staying private longer and reaching much greater scale before IPO, which is pushing more of the value creation that historically occurred in public markets into private growth rounds.

If you're asking because you're raising a round, tell me the company's sector, ARR/revenue, growth rate, EBITDA (if any), and target round size, and I can give you a much more useful 10–20-firm target list, ranked by who is genuinely likely to lead the round versus merely being a recognizable name.

Top-tier traditional private equity (PE) mega-funds and large-cap alternative asset managers have increasingly established dedicated growth equity and tech-opportunity arms to capture earlier, high-growth, and late-stage venture deals.

The primary traditional PE and mega-funds actively moving down-market into growth and earlier expansion-stage deals include:

• Blackstone Growth (BXG) : Blackstone's dedicated growth equity investing arm focuses on minority and majority investments in fast-scaling, disruptive enterprises—particularly in software, consumer, and healthcare tech—allowing them to bridge traditional buyouts with earlier growth rounds.
• KKR Next Generation Technology / KKR Growth : KKR built out dedicated growth equity strategies to target high-growth tech, software, and digital services companies, routinely writing checks for earlier, growth-inflection stage businesses rather than waiting exclusively for mature LBO targets.
• TPG Growth : One of the earliest mega-fund pioneers in this space , TPG Growth operates alongside its core buyout strategies to invest in dynamic, mid-to-late growth-stage companies across tech, healthcare, and consumer platforms.
• Bain Capital Tech Opportunities : A dedicated strategy by Bain Capital that targets growth-stage technology companies, applying a hybrid of venture-style market sizing and operational PE value-creation playbooks.
• Warburg Pincus (Growth Capital) : Long recognized as a premier global growth investor , Warburg Pincus frequently moves upstream and downstream in tech, financial services, and healthcare, backing scaling companies well ahead of traditional buyout timelines.

Would you like to explore specific sectors (like enterprise SaaS, fintech, or healthcare) or compare the check sizes and deal structures these PE-backed growth arms use versus traditional venture capital?

Yes. There’s a meaningful shift among the mega-firms toward growth equity / growth buyouts / structured minority investments—often earlier than the traditional “$50M+ EBITDA control buyout” sweet spot.

If by “top-tier” you mean firms with a major brand, institutional scale, and the ability to write $50M–$500M+ checks, I’d put these at the top of the list:

The ones I'd watch most closely

1. TPG — probably the cleanest answer

TPG explicitly says its Growth platform is designed to invest in companies that are “earlier in their lifecycle” and smaller than the companies targeted by its flagship Capital platform. TPG Growth includes both growth equity and growth buyouts. As of March 2026, the broader Growth platform had $32B of AUM, including $18.9B in TPG Growth and $8.8B in TPG Tech Adjacencies.

The interesting piece is Tech Adjacencies: it can do minority/structured investments and provide liquidity to founders, employees and early investors—so this is quite a bit earlier than conventional PE.

2. KKR

KKR is increasingly interesting if you're looking for a company that's too mature for VC but too early for traditional KKR buyout. Its growth strategy gives the firm a way to invest behind high-growth companies without requiring a conventional control transaction.

I'd especially consider KKR when the company has institutional-quality management, strong recurring revenue, and a credible path to becoming a $1B+ enterprise.

3. General Atlantic

GA isn't really “starting” to do growth—it's one of the firms that helped define the category. But if your thesis is top-tier PE firms moving earlier, GA is an important benchmark because it demonstrates what the institutionalized growth-equity model looks like.

4. Insight Partners

Same caveat: Insight has been a growth investor for years rather than a traditional PE firm suddenly moving downstream. But for B2B software, data, cybersecurity, AI and tech-enabled services, it belongs near the top of the list.

5. Blackstone

Blackstone is particularly interesting because its enormous platform lets it approach companies through several different forms of capital rather than forcing everything into a traditional buyout structure.

It's also becoming increasingly aggressive around technology/AI. For example, Blackstone partnered with Apollo in a $35B AI infrastructure transaction in June 2026. That's not a growth-equity deal in the conventional sense, but it illustrates how the mega-funds are increasingly willing to provide enormous amounts of flexible capital around earlier-stage/high-growth businesses and infrastructure.

A useful distinction

I'd actually divide the market into three groups:

A. “True growth equity” firms

• General Atlantic
• Insight Partners
• Summit Partners
• TPG Growth
• Silver Lake
• Francisco Partners Growth
• Permira Growth

These are the firms I'd call if you're a $20M–$100M revenue company growing 30–50%+ and don't want a traditional leveraged buyout.

B. Mega-PE firms building earlier-stage capabilities

• KKR
• Blackstone
• Bain Capital
• TPG
• Apollo
• Advent
• Thoma Bravo

These are particularly interesting because they can potentially follow a company from growth investment → control investment → very large buyout.

C. Hybrid / structured-capital players

This is arguably the most interesting emerging category:

• TPG Tech Adjacencies
• KKR Strategic Growth / growth strategies
• Blackstone Tactical Opportunities
• Apollo Hybrid Value
• Silver Lake
• Goldman Sachs Alternatives

These investors can do minority equity, preferred equity, structured equity, founder liquidity, secondary transactions, or growth capital rather than insisting on control.

Apollo, for example, describes its Hybrid Value business as providing flexible capital to entrepreneurs, management teams and sponsors through both debt and equity.

If you're thinking about this from the founder's perspective

The sweet spot I'd target is roughly:

$20–150M revenue + 25%+ growth + strong gross margins + credible path to $100M+ EBITDA.

At that point, you can potentially have VC/growth investors, crossover investors, and PE growth platforms all competing, rather than being limited to traditional growth equity.

And the really interesting development is that firms such as TPG, KKR and Blackstone can now offer a company multiple financing paths over its life. A founder might take a $50M minority investment today, sell another $100M of shares two years later, and eventually sell control to the same platform—without ever having to go through a conventional VC → investment bank → LBO sequence.

If you tell me the company's approximate revenue, growth rate, EBITDA (or burn), industry, and desired check size, I can narrow this down to the 10–15 firms most likely to actually bid, rather than just the firms with a growth strategy.

Traditional mega-cap and large-scale private equity (PE) firms have increasingly moved down-market into growth equity and late-stage venture deals to capture higher-multiple returns and hedge against a slower traditional buyout cycle.

The primary traditional PE and alternative asset management giants that have established prominent, dedicated growth-stage and technology-focused platforms include:

• KKR Operates KKR Growth , deploying capital out of strategies like their Next Generation Technology Fund to target fast-growing enterprise software, security, and tech-enabled businesses.
• Blackstone Runs Blackstone Growth (BXG) , which focuses on minority and majority growth investments in high-growth sectors like enterprise software, consumer, and healthcare.
• Bain Capital Features Bain Capital Tech Opportunities and Bain Capital Ventures (BCV) , actively bridging the gap from early-stage venture rounds to growth-stage scaling.
• TPG Manages TPG Growth , one of the industry's early and most established middle-market and growth equity arms targeting dynamic sectors ahead of public readiness or major M&A.
• Carlyle Continues to scale its dedicated growth capital and venture-focused investing teams, particularly focusing on technology and business services.
• General Atlantic A massive dedicated global growth equity pioneer that routinely participates in major late-stage and expansive inflection-point rounds for category-leading disruptors.
• Insight Partners Operates as a hybrid powerhouse, combining traditional growth equity with dedicated scale-up and late-stage tech/SaaS investments.

If you'd like, let me know:

• What specific sector (e.g., enterprise SaaS, fintech, healthcare, AI) you are tracking
• Whether you are looking for minority growth checks versus growth buyouts

I can narrow down which of these firms have been the most active recently.

The boundary between traditional private equity (PE), growth equity, and venture capital (VC) has blurred significantly. Major large-cap and mega-fund PE houses—traditionally known for leveraged buyouts (LBOs) of mature, cash-flowing enterprises—have launched dedicated growth arms or increasingly participate in earlier, growth-stage rounds (Series B through Series D) to capture high-multiple tech and healthcare returns.

Top-tier private equity and hybrid multi-stage firms active in earlier growth-stage deals include:

• Bain Capital (via Bain Capital Tech Opportunities & BCV) — While Bain Capital Private Equity focuses on massive buyouts [0.5], its tech-focused and venture arms actively target early-to-growth-stage infrastructure, SaaS, and cybersecurity startups, often bringing a PE-level operational playbook to earlier rounds.
• Blackstone Growth (BXG) — Blackstone’s dedicated growth equity platform invests in hyper-growth, entrepreneurial-led companies, frequently participating in pre-IPO and late-growth rounds across tech, consumer, and healthcare sectors.
• Insight Partners — Operating as a hybrid of venture capital and growth-stage private equity, Insight is one of the most prolific global investors in software and scale-ups, frequently dropping down into competitive growth rounds and utilizing an extensive in-house operator bench.
• General Atlantic — A pioneer of the growth equity asset class, General Atlantic bridges traditional PE governance with growth-stage investing, targeting high-growth sectors globally from tech and fintech to healthcare.
• KKR (via KKR Growth) — KKR expanded its multi-strategy platform to target growth equity, focusing on tech, healthcare, and digital transformation where they can position portfolio companies for ultimate buyouts or public debuts.
• TPG (via TPG Growth) — TPG maintains dedicated vehicles for minority growth investments, writing substantial checks into earlier-stage category leaders in consumer, digital platforms, and healthcare without requiring immediate board control.
• Summit Partners — A premier alternative investment firm focused strictly on growth equity, Summit partners with category-leading tech and healthcare companies, frequently taking minority or flexible growth stakes rather than rigid buyout structures.
• Sixth Street Growth — The dedicated growth investing platform of Sixth Street, this team targets mid- and late-stage growth companies with flexible, differentiated capital solutions to scale enterprise software and tech disruptors.

If you're targeting a specific sector like enterprise SaaS, fintech, or healthcare , I can narrow down which of these firms is writing the most active checks right now.

Yes. If by “earlier” you mean firms that traditionally played in buyouts but are increasingly willing to invest in companies that are still scaling—often minority or structured growth investments rather than classic control deals, there’s a meaningful group of top-tier names to watch.

The strongest names

The important distinction

I'd divide the market into three buckets:

1. “Mega-PE that has moved down-market”
KKR, TPG, Blackstone, Apollo, Carlyle.

These firms have enormous traditional buyout franchises, but increasingly have growth, technology, middle-market, structured-equity or flexible-capital vehicles that can invest earlier than their flagship funds.

2. “Elite growth investors that look like PE”
General Atlantic, Summit Partners, Insight Partners, Thoma Bravo Growth, Francisco Partners' growth-oriented strategies.

These are often more natural homes for a company that is $20–100M+ revenue, growing quickly, and not yet ready for a conventional $1B+ buyout.

3. “PE firms deliberately building a continuum from growth → buyout”

This is the most interesting trend. The large platforms increasingly want to be able to invest in the same company multiple times across its lifecycle—growth equity today, control buyout later, credit/capital solutions when appropriate.

TPG is particularly explicit about this: it says its Growth platform exists to invest in companies that are earlier in their lifecycle or smaller than what its main Capital platform would consider.

KKR has a similar architecture: its platform now spans Tech Growth, Health Care Growth, Middle Market and traditional buyouts.

If you're asking because you're raising capital

I'd be especially interested in TPG, KKR, General Atlantic, Summit, Insight and Thoma Bravo depending on the company's sector and size.

The really interesting question is how far down the revenue/EBITDA curve each firm's growth strategy is actually willing to go today. That's substantially different from what their websites imply, and it's where the practical investor list gets much more useful.

If you tell me the company's rough revenue, growth rate, EBITDA (if any), sector, and desired check size, I can give you a much more targeted 10–20-firm “who would actually take this deal” list, including which firms are likely to lead vs. co-invest.